Bispecific antibody therapy could enhance multiple myeloma treatment at the community level, improving patient access to advanced care. Key challenges include logistical hurdles, such as the need for ...
Multiple myeloma is a blood cancer affecting plasma cells, causing abnormal antibody production and bone damage. Diagnosis involves blood tests, bone marrow biopsy, imaging, and genetic analysis to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results